http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-813084-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5712b4838bdb16ebbc41121239e165b9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
filingDate 1981-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1982-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-813084-L
titleOfInvention Pentacyclic pyrazinoquinoline derivatives
abstract Compounds of formula (I): <IMAGE> (I) wherein: X is CH2, O, S or NR wherein R is hydrogen or C1-4 alkyl; Y and Z are independently selected from hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen or CF3; R1 is hydrogen, C1-6 alkyl, phenyl or phenyl-C1-4 alkyl any of which phenyl moieties may be substituted by one or more of C1-6 alkyl, C1-6 alkoxy, halogen or CF3; R2 is hydrogen, OH, C1-6 alkoxy, phenyl-C1-4 alkoxy, C1-7 acyloxy or NR4R5 wherein R4 and R5 are independently selected from hydrogen or C1-6 alkyl; R4 is hydrogen and R5 is OH or C1-4 alkoxy; or R4 and R5 together form C3-6 polymethylene optionally interrupted by O or NR6 where R6 is hydrogen or C1-4 alkyl; or together with R1 forms an oxo group or =NOR7 wherein R7 is hydrogen or C1-6 alkyl; and R3 is hydrogen or C1-6 alkyl have useful pharmacological activity, processes for their preparation and their use.n[US4442098A]
priorityDate 1980-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414036616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18432738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803

Total number of triples: 31.